| Name | Title | Contact Details |
|---|
NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington`s disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been “undruggable.” for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase`s pipeline includes
CCTC passionately serves the emotional needs of children and families at risk beginning in early childhood.
MHC Healthcare is a network of health centers focused on serving the communities where our patients live. We promote and support accessible and affordable primary health care services for all individuals independent of socio-economic status, national o...
Sertech is a Batavia, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hs Pharma is a Greenville, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.